Pfizer Could Apply for Emergency Use of COVID-19 Vaccine by Late November
Share
[aggregation-styles]
The Wall Street Journal Subscription
Pfizer Inc. laid out a timetable for reaching key milestones in the development of its Covid-19 vaccine that could mean the shots start becoming available in the U.S. before year’s end.
Chief Executive Albert Bourla said Friday the company could start to see from a large study whether the vaccine works by the end of this month and would have data on its safety by the third week of November. If the preliminary results indicate the vaccine can work safely, Pfizer could ask U.S. health regulators to permit use by late November.
Read More →
The Wall Street Journal Subscription
Pfizer Inc. laid out a timetable for reaching key milestones in the development of its Covid-19 vaccine that could mean the shots start becoming available in the U.S. before year’s end.
Chief Executive Albert Bourla said Friday the company could start to see from a large study whether the vaccine works by the end of this month and would have data on its safety by the third week of November. If the preliminary results indicate the vaccine can work safely, Pfizer could ask U.S. health regulators to permit use by late November.
Read More →
RELATED TOPICS:
Categories
Latest
Videos
National /
7 hours ago
Hegseth Orders the Name of Gay Rights Activist Harvey Milk Scrubbed From Navy Ship
Sports /
7 hours ago
Knicks Fire Coach Tom Thibodeau After First Eastern Conference Finals Berth in 25 Years
Opinion /
10 hours ago
